Electron Kebebew, MD, FACS

Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

4.9/5

78 Patient Ratings »

89 Patient Reviews »

Biography

Dr. Electron Kebebew is an internationally recognized expert in Endocrine Oncology and Surgery. He has performed more than four thousand operations on the adrenal, parathyroid, and thyroid glands, and for neuroendocrine tumors of the gastrointestinal tract and pancreas. He has given over 200 invited lectures and visiting professorships. His clinical and translational studies on endocrine and neuroendocrine tumors have been awarded more than $30 million in research funding. Dr. Kebebew has authored and coauthored over 400 scientific articles, 40 book chapters, and edited or co-edited four textbooks. His scientific contributions include the use of molecular markers in thyroid nodule to refine diagnosis and prognostication, identification of novel target for endocrine cancer therapy, implementation of genetic testing and advanced imaging modality to optimize the management of patients with endocrine neoplasm and to allow the practice of precision surgery, and the identification and characterization of inherited endocrine and neuroendocrine syndromes, and their susceptibility genes.

View Full Biography »

Professional Summary

Professional Education

Board Certification: American Board of Surgery, General Surgery (2003)
Residency: UCSF General Surgery Residency (2002) CA
Postdoctoral training, NCI T32 fellowship, Cancer Biology (1998)

Medical Education: University of California at San Francisco School of Medicine (1995) CA

Publications

Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas
Campbell, J. D., Yau, C., Bowlby, R., Liu, Y., Brennan, K., Fan, H., … Van Waes, C. (2018). Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. CELL REPORTS, 23(1), 194-+.
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Yang, T.-H. O., … Shmulevich, L. (2018). The Immune Landscape of Cancer. IMMUNITY, 48(4), 812-+.
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
Liu, Y., Sethi, N. S., Hinoue, T., Schneider, B. G., Cherniack, A. D., Sanchez-Vega, F., … Laird, P. W. (2018). Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. CANCER CELL, 33(4), 721-+.

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., … Wiznerowicz, M. (2018). Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. CELL, 173(2), 338-+.

Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism
Sadowski, S. M., Pusztaszeri, M., Brulhart-Meynet, M.-C., Petrenko, V., De Vito, C., Sobel, J., … Dibner, C. (2018). Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 103(6), 2189–98.

Neural monitoring in endocrine neck surgery
El Lakis, M., & Kebebew, E. (2018). Neural monitoring in endocrine neck surgery. GLAND SURGERY, 7, S86–S88.

Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection
Nockel, P., Tirosh, A., El Lakis, M., Gaitanidis, A., Merkel, R., Patel, D., … Kebebew, E. (2018). Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection. ENDOCRINE, 61(3), 422–27.

Aggressive resection of neuroendocrine tumor (NET) liver metastases: NET neutral or gain?
Cisco, R., Lin, D., & Kebebew, E. (2018). Aggressive resection of neuroendocrine tumor (NET) liver metastases: NET neutral or gain? Surgery.

Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database
Tella, S. H., Kommalapati, A., Yaturu, S., & Kebebew, E. (2018). Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 103(9), 3566–73.

Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors.
Tirosh, A., Journy, N., Folio, L. R., Lee, C., Leite, C., Yao, J., … de Gonzalez, A. B. (2018). Cumulative Radiation Exposures from CT Screening and Surveillance Strategies for von Hippel-Lindau-associated Solid Pancreatic Tumors. Radiology, 180687.

Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver.
Keutgen, X. M., Schadde, E., Pommier, R. F., Halfdanarson, T. R., Howe, J. R., & Kebebew, E. (2018). Metastatic neuroendocrine tumors of the gastrointestinal tract and pancreas: A surgeon's plea to centering attention on the liver. Seminars in Oncology.

Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors
Gara, S. K., Lack, J., Zhang, L., Harris, E., Cam, M., & Kebebew, E. (2018). Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors. NATURE COMMUNICATIONS, 9, 4172.

Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.
El Lakis, M., Gianakou, A., Nockel, P., Wiseman, D., Tirosh, A., Quezado, M. A., … Kebebew, E. (2018). Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors. JAMA Surgery.

ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors.
Gaitanidis, A., Patel, D., & Kebebew, E. (2018). ASO Author Reflections: Systemic Inflammatory Markers in Pancreatic Neuroendocrine Tumors. Annals of Surgical Oncology.

Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness.
Boufraqech, M., Patel, D., Nilubol, N., Powers, A. S., King, T., Shell, J., … Kebebew, E. (2018). Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness. Thyroid : Official Journal of the American Thyroid Association.

Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
El Lakis, M., Giannakou, A., Nockel, P. J., Wiseman, D., Gara, S. K., Patel, D., … Kebebew, E. (2018). Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. Surgery.

Curbing Unnecessary and Wasted Diagnostic Imaging.
Oren, O., Kebebew, E., & Ioannidis, J. P. (2019). Curbing Unnecessary and Wasted Diagnostic Imaging. JAMA.

Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.
Tirosh, A., Mukherjee, S., Lack, J., Gara, S. K., Wang, S., Quezado, M. M., … Kebebew, E. (2019). Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors. Cancer.

Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry.
Hurst, Z., Liyanarachchi, S., He, H., Brock, P., Sipos, J. A., Nabhan, F., … Jhiang, S. M. (2019). Risk Haplotypes Uniquely Associated with Radioiodine Refractory Thyroid Cancer Patients of High African Ancestry. Thyroid : Official Journal of the American Thyroid Association.

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer.
Klubo-Gwiezdzinska, J., Auh, S., Gershengorn, M., Daley, B., Bikas, A., Burman, K., … Kebebew, E. (2019). Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer. JAMA Network Open, 2(2), e187754.

ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.
Tirosh, A., Killian, J. K., Zhu, Y. J., Petersen, D., Walling, J., Mor-Cohen, R., … Kebebew, E. (2019). ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
Lakis, M. E., & Kebebew, E. (2019). Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. Surgery.

Neural monitoring in endocrine neck surgery.
El Lakis, M., & Kebebew, E. (2018). Neural monitoring in endocrine neck surgery. Gland Surgery, 7(Suppl 1), S86–S88.

Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors
Tirosh, A., Mukherjee, S., Lack, J., Gara, S. K., Wang, S., Quezado, M. M., … Kebebew, E. (2019). Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors. CANCER, 125(8), 1247–57.

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer
Klubo-Gwiezdzinska, J., Auh, S., Gershengorn, M., Daley, B., Bikas, A., Burman, K., … Kebebew, E. (2019). Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer. JAMA NETWORK OPEN, 2(2).

Four-Gland Exploration Versus Focused Parathyroidectomy for Hyperparathyroidism Jaw Tumor Syndrome
Patel, D., & Kebebew, E. (2018). Four-Gland Exploration Versus Focused Parathyroidectomy for Hyperparathyroidism Jaw Tumor Syndrome. DIFFICULT DECISIONS IN ENDOCRINE SURGERY: AN EVIDENCE-BASED APPROACH, 227–37.

MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
Ruff, S. M., Ayabe, R. I., Malekzadeh, P., Good, M. L., Wach, M. M., Gonzales, M. K., … Patel, D. (2019). MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas. The Journal of Surgical Research, 243, 1–7.

Solutions to Reduce Unnecessary Imaging-Reply.
Oren, O., Kebebew, E., & Ioannidis, J. P. (2019). Solutions to Reduce Unnecessary Imaging-Reply. JAMA, 321(22), 2243.

ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS
Tirosh, A., Killian, J. K., Zhu, Y. J., Petersen, D., Walling, J., Mor-Cohen, R., … Kebebew, E. (2019). ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS. ENDOCRINE PRACTICE, 25(6), 580–88.

National Treatment Practice for Adrenocortical Carcinoma: Have they changed and have we made any progress?
Tierney, J. F., Chivukula, S. V., Poirier, J., Pappas, S. G., Schadde, E., Hertl, M., … Keutgen, X. (2019). National Treatment Practice for Adrenocortical Carcinoma: Have they changed and have we made any progress? The Journal of Clinical Endocrinology and Metabolism.

Long noncoding RNAs in thyroid cancer.
Sedaghati, M., & Kebebew, E. (2019). Long noncoding RNAs in thyroid cancer. Current Opinion in Endocrinology, Diabetes, and Obesity.

The Immune Landscape of Cancer.
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., … Shmulevich, I. (2019). The Immune Landscape of Cancer. Immunity, 51(2), 411–12.

Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand, F. O., Liu-Chittenden, Y., Fan, Y., Tirosh, A., Gara, S. K., Patel, D., … Kebebew, E. (2019). Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy. Surgery.

Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels.
Good, M. L., Malekzadeh, P., Ruff, S. M., Gupta, S., Copeland, A., Pacak, K., … Patel, D. (2019). Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels. World Journal of Surgery.

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
Thakur, S., Tobey, A., Daley, B., Auh, S., Walter, M., Patel, D., … Klubo-Gwiezdzinska, J. (2019). Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III). FRONTIERS IN ONCOLOGY, 9.

Resection of the Primary Tumor in Patients with Distant Thyroid Cancer Metastasis Is Associated with Longer Survival
Sedaghati, M., Lin, D. T., Cisco, R. M., & Kebebew, E. (2019). Resection of the Primary Tumor in Patients with Distant Thyroid Cancer Metastasis Is Associated with Longer Survival. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S82.

Pediatric vs Adult Adrenocortical Carcinoma: Different Rate of Surgical Treatment and Patient Outcome
Sedaghati, M., Lin, D. T., Cisco, R. M., & Kebebew, E. (2019). Pediatric vs Adult Adrenocortical Carcinoma: Different Rate of Surgical Treatment and Patient Outcome. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 229(4), S81–S82.

NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer.
Orois, A., Gara, S. K., Mora, M., Halperin, I., Martinez, S., Alfayate, R., … Oriola, J. (2019). NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer. Genes, 10(11).

Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment
el Lakis, M., & Kebebew, E. (2019). Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment. SURGERY, 165(6), 1246–47.

Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma.
Gaitanidis, A., Wiseman, D., El Lakis, M., Nilubol, N., Kebebew, E., & Patel, D. (2019). Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma. Journal of Surgical Oncology.

30th Anniversary and The Future of Thyroid.
Kebebew, E. (2019). 30th Anniversary and The Future of Thyroid. Thyroid : Official Journal of the American Thyroid Association.

A combinatorial strategy for targeting BRAF V600E mutant cancers with BRAF V600E inhibitor (PLX4720) and tyrosine kinase inhibitor (ponatinib).
Kebebew, E., Ghosh, C., Kumar, S., Kushchayeva, Y., Gaskins, K., Boufraqech, M., … Mukherjee, S. (2020). A combinatorial strategy for targeting BRAF V600E mutant cancers with BRAF V600E inhibitor (PLX4720) and tyrosine kinase inhibitor (ponatinib). Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.

A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
Smith, D. C., Kroiss, M., Kebebew, E., Habra, M. A., Chugh, R., Schneider, B. J., … Naing, A. (2020). A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma. Investigational New Drugs.

Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., … Carty, S. E. (2020). Executive Summary of the American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Annals of Surgery, 271(3), 399–410.

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
Patel, K. N., Yip, L., Lubitz, C. C., Grubbs, E. G., Miller, B. S., Shen, W., … Carty, S. E. (2020). The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Annals of Surgery, 271(3), e21–e93.

An update on familial nonmedullary thyroid cancer.
Ammar, S. A., Alobuia, W. M., & Kebebew, E. (2020). An update on familial nonmedullary thyroid cancer. Endocrine.

Surgery for adrenocortical carcinoma: When and how?
Sinclair, T. J., Gillis, A., Alobuia, W. M., Wild, H., & Kebebew, E. (2020). Surgery for adrenocortical carcinoma: When and how? Best Practice & Research. Clinical Endocrinology & Metabolism, 101408.

Editorial: Translational Research in Thyroid Cancer.
Vasko, V., Kebebew, E., Cheng, S.-Y. Y., & Jensen, K. E. (2020). Editorial: Translational Research in Thyroid Cancer. Frontiers in Endocrinology, 11, 224.

Genetic testing in endocrine surgery: Opportunities for precision surgery.
Alobuia, W., Annes, J., & Kebebew, E. (2020). Genetic testing in endocrine surgery: Opportunities for precision surgery. Surgery.

Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not?
Sung, T.-Y. Y., Alobuia, W. M., Tyagi, M. V., Ghosh, C., & Kebebew, E. (2020). Adrenal Vein Sampling to Distinguish Between Unilateral and Bilateral Primary Hyperaldosteronism: To ACTH Stimulate or Not? Journal of Clinical Medicine, 9(5).

Pan-cancer analysis of whole genomes
Campbell, P. J., Getz, G., Korbel, J. O., Stuart, J. M., Jennings, J. L., Stein, L. D., … Zhang, J. (2020). Pan-cancer analysis of whole genomes. NATURE, 578(7793), 82-+.

Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA.
Alobuia, W. M., Dalva-Baird, N. P., Forrester, J. D., Bendavid, E., Bhattacharya, J., & Kebebew, E. (2020). Racial disparities in knowledge, attitudes and practices related to COVID-19 in the USA. Journal of Public Health (Oxford, England).

Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines.
Seib, C. D., Meng, T., Suh, I., Cisco, R. M., Lin, D. T., Morris, A. M., … Kebebew, E. (2020). Undertreatment of primary hyperparathyroidism in a privately insured US population: Decreasing utilization of parathyroidectomy despite expanding surgical guidelines. Surgery.

Genetic and epigenetic alterations in pancreatic neuroendocrine tumors
Tirosh, A., & Kebebew, E. (2020). Genetic and epigenetic alterations in pancreatic neuroendocrine tumors. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 11(3), 567–77.

Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.
Wiseman, D., McDonald, J. D., Patel, D., Kebebew, E., Pacak, K., & Nilubol, N. (2020). Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma. Endocrine-Related Cancer.

Distinct DNA methylation signatures in neuroendocrine tumors specific for primary site and inherited predisposition.
Tirosh, A., Killian, J. K., Petersen, D., Zhu, Y. J., Walker, R. L., Blau, J. E., … Kebebew, E. (2020). Distinct DNA methylation signatures in neuroendocrine tumors specific for primary site and inherited predisposition. The Journal of Clinical Endocrinology and Metabolism.

Contemporary Management of Anaplastic Thyroid Cancer.
Alobuia, W., Gillis, A., & Kebebew, E. (2020). Contemporary Management of Anaplastic Thyroid Cancer. Current Treatment Options in Oncology, 21(10), 78.

GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.
Gara, S. K., Tyagi, M. V., Patel, D. T., Gaskins, K., Lack, J., Liu, Y., & Kebebew, E. (2020). GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3. Oncotarget, 11(36), 3354–70.

Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history.
Alobuia, W. M., Ammar, S., Tyagi, M., Ghosh, C., Gunda, V., Annes, J. P., & Kebebew, E. (2020). Probability of positive genetic testing in patients diagnosed with pheochromocytoma and paraganglioma: Criteria beyond a family history. Surgery.

Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland.
Gubbi, S., Thakur, S., Avadhanula, S., Araque, K. A., Filie, A. C., Raffeld, M., … Klubo-Gwiezdzinska, J. (2020). Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland. The Lancet. Oncology, 21(11), e528–e537.

Comprehensive guidance on the diagnosis and managemen of primary mesenchymal tumours of the thyroid gland
Gubbi, S., Thakur, S., Avadhanula, S., Araque, K. A., Filie, A. C., Raffeld, M., … Klubo-Gwiezdzinska, J. (2020). Comprehensive guidance on the diagnosis and managemen of primary mesenchymal tumours of the thyroid gland. LANCET ONCOLOGY, 21(11), E528–E537.

Thyroid 2020 to 2021.
Kebebew, E. (2020). Thyroid 2020 to 2021. Thyroid : Official Journal of the American Thyroid Association.

IMMUNE PROFILING TO PREDICT RECOVERY OUTCOMES AFTER SURGERY
Tsai, E. S., Rumer, K., Wong, K., Warrington, B., Shelton, E., Ganio, E., … Gaudilliere, B. (2020). IMMUNE PROFILING TO PREDICT RECOVERY OUTCOMES AFTER SURGERY. SHOCK. LIPPINCOTT WILLIAMS & WILKINS.

Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism.
Seib, C. D., Suh, I., Meng, T., Trickey, A., Smith, A. K., Finlayson, E., … Kebebew, E. (2021). Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism. JAMA Surgery.

2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
Bible, K. C., Kebebew, E., Brierley, J., Brito, J. P., Cabanillas, M. E., Clark, T. J., … Wong-Clark, C. K. (2021). 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid : Official Journal of the American Thyroid Association, 31(3), 337–86.

Adrenal Incidentaloma.
Kebebew, E. (2021). Adrenal Incidentaloma. The New England Journal of Medicine, 384(16), 1542–51.

Association of parathyroidectomy with 5-year clinically significant kidney stone events in patients with primary hyperparathyroidism.
Seib, C. D., Ganesan, C., Arnow, K. D., Suh, I., Pao, A. C., Leppert, J. T., … Kebebew, E. (2021). Association of parathyroidectomy with 5-year clinically significant kidney stone events in patients with primary hyperparathyroidism. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims.
Alobuia, W. M., Meng, T., Cisco, R. M., Lin, D. T., Suh, I., Tamura, M. K., … Seib, C. D. (2021). Racial disparities in the utilization of parathyroidectomy among patients with primary hyperparathyroidism: Evidence from a nationwide analysis of Medicare claims. Surgery.

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath, K., Welch, J., Gubbi, S., Veeraraghavan, P., Avadhanula, S., Gara, S. K., … Klubo-Gwiezdzinska, J. (2021). Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study. Frontiers in Endocrinology, 12, 653401.

Adrenal Incidentaloma. Reply.
Kebebew, E. (2021). Adrenal Incidentaloma. Reply. The New England Journal of Medicine, 385(8), 768.

Adrenal Incidentaloma REPLY
Kebebew, E. (2021). Adrenal Incidentaloma REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 385(8), 768.

This Year in Thyroid and Farewell.
Kebebew, E. (2021). This Year in Thyroid and Farewell. Thyroid : Official Journal of the American Thyroid Association.

Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management.
Seib, C. D., Meng, T., Suh, I., Harris, A. H., Covinsky, K. E., Shoback, D. M., … Tamura, M. K. (2021). Risk of Fracture Among Older Adults With Primary Hyperparathyroidism Receiving Parathyroidectomy vs Nonoperative Management. JAMA Internal Medicine.

Factors associated with postoperative complications and costs for adrenalectomy in benign adrenal disorders.
Sung, T.-Y., Tennakoon, L., Alobuia, W. M., Seib, C., Cisco, R., Lin, D., & Kebebew, E. (2021). Factors associated with postoperative complications and costs for adrenalectomy in benign adrenal disorders. Surgery.

Treatment for Advanced and Metastatic Thyroid Cancer Refractory to Standard Treatment-We Need to Know the When, What, and Who.
Kebebew, E. (1800). Treatment for Advanced and Metastatic Thyroid Cancer Refractory to Standard Treatment-We Need to Know the When, What, and Who. JAMA Oncology.

Integrated Single-Cell and Plasma Proteomic Modeling to Predict Surgical Site Complications: A Prospective Cohort Study.
Rumer, K. K., Hedou, J., Tsai, A., Einhaus, J., Verdonk, F., Stanley, N., … Gaudilliere, B. (1800). Integrated Single-Cell and Plasma Proteomic Modeling to Predict Surgical Site Complications: A Prospective Cohort Study. Annals of Surgery.

SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas.
Armstrong, N., Storey, C. M., Noll, S. E., Margulis, K., Soe, M. H., Xu, H., … Annes, J. P. (2022). SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas. Cell Reports, 38(9), 110453.

Kidney stone events following parathyroidectomy vs. non-operative management for primary hyperparathyroidism.
Seib, C. D., Ganesan, C., Arnow, K. D., Pao, A. C., Leppert, J. T., Barreto, N. B., … Tamura, M. K. (2022). Kidney stone events following parathyroidectomy vs. non-operative management for primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism.

Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-Like Pheochromocytomas
Armstrong, N., Storey, C. M., Noll, S. E., Margulis, K., Soe, M. H., Xu, H., … Annes, J. P. (2022). Succinate Accumulation Is Not Sufficient for Tumorigenesis in Mouse Chromaffin Cells But Dual Loss of SDHB and NF1 Yields SDHx-Like Pheochromocytomas. PANCREAS. LIPPINCOTT WILLIAMS & WILKINS.

Adverse Cardiovascular Outcomes Among Older Adults with Primary Hyperparathyroidism Treated with Parathyroidectomy vs. non-operative Management.
Seib, C. D., Meng, T., Cisco, R. M., Suh, I., Lin, D. T., Harris, A. H., … Kebebew, E. (2022). Adverse Cardiovascular Outcomes Among Older Adults with Primary Hyperparathyroidism Treated with Parathyroidectomy vs. non-operative Management. Annals of Surgery.

Integrated single-cell and plasma proteomic modeling to predict surgical site complications, a prospective cohort study
Tsai, A. S., Hedou, J., Einhaus, J., Rumer, K., Verdonk, F., Stanley, N., … Gaudilliere, B. (2022). Integrated single-cell and plasma proteomic modeling to predict surgical site complications, a prospective cohort study. ANESTHESIA AND ANALGESIA. LIPPINCOTT WILLIAMS & WILKINS.

Just a Little Bit of Anaplastic Thyroid Cancer?
Kebebew, E. (2022). Just a Little Bit of Anaplastic Thyroid Cancer? Annals of Surgical Oncology.

Risk of permanent hypoparathyroidism requiring calcitriol therapy in a population-based cohort of adults older than 65 undergoing total thyroidectomy for Graves' disease.
Seib, C. D., Meng, T., Cisco, R. M., Lin, D. T., McAninch, E. A., Chen, J., … Kebebew, E. (2022). Risk of permanent hypoparathyroidism requiring calcitriol therapy in a population-based cohort of adults older than 65 undergoing total thyroidectomy for Graves' disease. Thyroid : Official Journal of the American Thyroid Association.

A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery.
Sehnem, L. J., Noureldine, S. I., Avci, S., Isiktas, G., Elshamy, M., Saito, Y., … Berber, E. (2023). A multicenter evaluation of near-infrared autofluorescence imaging of parathyroid glands in thyroid and parathyroid surgery. Surgery, 173(1), 132–137.

In Memoriam: Orlo H. Clark, MD (1941-2022).
Shen, W. T., Kebebew, E., Shoback, D., Liu, C., Gosnell, J. E., & Caron, N. R. (2023). In Memoriam: Orlo H. Clark, MD (1941-2022). Thyroid : Official Journal of the American Thyroid Association.

A Contemporary Review of the Treatment of Medullary Thyroid Carcinoma in the Era of New Drug Therapies.
Seib, C. D., Beck, T. C., & Kebebew, E. (2023). A Contemporary Review of the Treatment of Medullary Thyroid Carcinoma in the Era of New Drug Therapies. Surgical Oncology Clinics of North America, 32(2), 233–250.

Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism.
Seib, C. D., Ganesan, C., Furst, A., Pao, A. C., Chertow, G. M., Leppert, J. T., … Tamura, M. K. (2023). Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism. Annals of Internal Medicine.

Increased Risk of Complications Associated With Concurrent Parathyroidectomy in Patients Undergoing Total Thyroidectomy.
Cisco, R., Arnow, K., Barreto, N., Lin, D., Kebebew, E., & Seib, C. (2023). Increased Risk of Complications Associated With Concurrent Parathyroidectomy in Patients Undergoing Total Thyroidectomy. The Journal of Surgical Research, 288, 275–281.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) »

Specializing In

Adrenal Gland Surgery
Adrenal Nodules
Adrenal Tumors
Complex pancreatic surgery
Endocrine Hypertension
Endocrine Surgery
Enucleation of pancreatic tumors
General Surgery
Goiter
Head and Neck Surgery
Hereditary Endocrine Disorders
Hyperaldosteronism
Hypercalcemia
Hyperparathyroidism

Hyperthyroidism

Hypoglycemia

Insulinoma

Laparoscopic Surgery

Left Upper Pole Partial Adrenalectomy

Minimally Invasive Endoscopy

Minimally invasive pancreatic resections

Minimally invasive parathyroid surgery

Neck Surgery

Neuroendocrine Tumors
Neurofibromatosis
Parathyroid Abnormality
Parathyroid Adenoma
Parathyroid Diseases
Parathyroid Surgery
Parathyroid Tumors and Disorders
Pheochromocytoma
Pheochromocytoma
Small Bowel Resection
Small Bowel Tumors
Spleen-preserving pancreatectomy
Surgical Oncology
The "Whipple"

Thyroid Cancer

Thyroid Disease

Thyroid Nodules

Thyroid Surgery

Thyroidectomy

Thyroiditis

Tuberous Sclerosis Complex

Von Hippel-Lindau Syndrome (VHL)

Practice Locations

Cancer Center in Emeryville Emeryville, CA

Emeryville, CA

Cancer Center in Emeryville

5800 Hollis Street

Emeryville , CA 94608

+1 (833) 444-7622

More Clinic Information »

Endocrine Tumor Program - 875 Blake Wilbur Drive Palo Alto, CA

Palo Alto, CA

Endocrine Tumor Program - 875 Blake Wilbur Drive

875 Blake Wilbur Drive

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information »

Endocrine Tumor Program in Emeryville Emeryville, CA

Emeryville, CA

Endocrine Tumor Program in Emeryville

5800 Hollis Street

Emeryville , CA 94608

+1 (833) 444-7622

More Clinic Information »

Neurogenetic Cancer Palo Alto, CA

Palo Alto, CA

Neurogenetic Cancer

213 Quarry Road

Palo Alto , CA 94304

(650) 497-7777

More Clinic Information »

Patient Ratings

(78 Ratings)

Overall Rating

4.9/5

View Ratings by Category

5.0/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

4.9/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(89 reviews)

He was thorough and answered all of my questions clearly. I appreciated the opportunity for a video visit vs making the 4.5 hour trip to Stanford and paying over $100 for the round trip gas for my car.

Mar 2023

•

Verified SHC Patient

I feel very lucky I was referred to him.

Mar 2023

•

Verified SHC Patient

Dr. Kebebew is an extremely talented surgeon and a caring, compassionate provider who takes the time to answer all my questions.

Feb 2023

•

Verified SHC Patient

Dr. Kebebew was amazing asked to see the surgical sight gave recommendations as to what I can do to continue to treat the wound. Dr. Kebebew was patient let me ask any questions I had. He also gave pathology results. I felt all my questions were answered, Dr. Kebebew also asked if there were any questions I had before ending the video visit.

Jan 2023

•

Verified SHC Patient

Heâ€™s the best

Jan 2023

•

Verified SHC Patient

He is the best, obviously

Dec 2022

•

Verified SHC Patient

Thank you so much for everything. Happy Holidays!

Dec 2022

•

Verified SHC Patient

great experience that the surgeon was present in meeting along with other care team professionals

Dec 2022

•

Verified SHC Patient

Iâ€™m so pleased to have him as my doctor

Dec 2022

•

Verified SHC Patient

Wonderful care!

Dec 2022

•

Verified SHC Patient

Was very patient when couldnâ€™t get voice connected. Answered all questions and very thorough

Dec 2022

•

Verified SHC Patient

I immediately felt quite comfortable with Dr. Benebew and his staff. He was very professional, kind, and explained the procedure in layman's terms.

Nov 2022

•

Verified SHC Patient

Deep gratitude for Dr Kebebew and his team. I could not have been in better hands.

Nov 2022

•

Verified SHC Patient

Excellent and caring dr.

Nov 2022

•

Verified SHC Patient

He explains expected goals and outcomes very clearly and concisely.

Nov 2022

•

Verified SHC Patient

Thank you for taking the time to answer all of my questions and for the excellent care that I received from you and all of your staff!

Nov 2022

•

Verified SHC Patient

I was able to see him in a timely manner, he and his team were kind, thoughtful and efficient with all my needs and questions. They made the process simple and easy for me. Great communication and follow through. Very pleased with my whole experience.

Nov 2022

•

Verified SHC Patient

Visit was smooth, well coordinated.

Oct 2022

•

Verified SHC Patient

Dr. Kebebew is an excellent, caring, kind physician.

Oct 2022

•

Verified SHC Patient

Thank you for your expertise in solving my medical issue!

Oct 2022

•

Verified SHC Patient

Fantastic depth of care and consideration taken with all the many questions.

Sep 2022

•

Verified SHC Patient

Thanks to Dr. Kebebew for reassuring me about my surgery experience for Hyperparathyroidism. I was confident I was in excellent hands. Dr. Kebebew explains things clearly and has a reassuring manner. Thank you, Dr. Kebebew!

Aug 2022

•

Verified SHC Patient

Great doctor!

Aug 2022

•

Verified SHC Patient

Thorough

Aug 2022

•

Verified SHC Patient

Dr. Kebebew is very thorough. He explained my diagnosis, procedure and hospital stay.

Aug 2022

•

Verified SHC Patient

Dr. Kebebew and his team were welcoming, attentive to the medical problem, and invited questions from me, which were listened to!

Jul 2022

•

Verified SHC Patient

Personal, professional and extremely competent.....outstanding physician...so glad to be his patient

Jul 2022

•

Verified SHC Patient

He is competent and explains the procedure well.

Jul 2022

•

Verified SHC Patient

Dr. Kebebew and his team were so professional, caring, efficiant and went above and beyond. I would highly recommend them.

Jun 2022

•

Verified SHC Patient

Exceptional clinician. Very thorough is his discussions with me. I feel very comfortable with his skill and decision making.

May 2022

•

Verified SHC Patient

He is excellent with strong professional skills

May 2022

•

Verified SHC Patient

He seems to be an excellent physician, kind, well spoken

Apr 2022

•

Verified SHC Patient

He seems to be competent and a caring doctor.

Apr 2022

•

Verified SHC Patient

I was impressed by the clarity he gave in explaining the surgical procedure.

Apr 2022

•

Verified SHC Patient

From the front desk staff, medical assistant, nurse and nurse practitioner everyone was professional and friendly. Dr. Kebebew is amazing and instills confidence. Wonderful team.

Apr 2022

•

Verified SHC Patient

Dr. Kebebew and his staff are the absolute best medical team to have provided my healthcare. There are no words to express my gratitude for Dr. Kebebew and his staff's professionalism, kindness, and compassion.

Apr 2022

•

Verified SHC Patient

I have never met him in person, but he seems to be a decent guy,

Apr 2022

•

Verified SHC Patient

The visit went great I have no comments at this time

Mar 2022

•

Verified SHC Patient

Dr. Kebebew explained my Fluocholine PETMR and provided optional treatments.

Mar 2022

•

Verified SHC Patient

Excellent surgeon!

Mar 2022

•

Verified SHC Patient

and helpful and generously offer most pertinent information.Dr. Kebebew and staff are most cordial

Mar 2022

•

Verified SHC Patient

Everyone on the team is very kind and professional.

Mar 2022

•

Verified SHC Patient

Dr Kebebew was easy to understand and explained everything perfectly, answered all questions on had

Mar 2022

•

Verified SHC Patient

Dr. Kebebew was very informative and answered all of my questions.

Feb 2022

•

Verified SHC Patient

I thought the video session allowed me to gather information and ask questions. Dr Kebebew was very thorough. I look forward to meeting him in person.

Feb 2022

•

Verified SHC Patient

Dr. Kebebew and his staff are so caring and professional. I feel confident in the health care they are providing to me.

Jan 2022

•

Verified SHC Patient

Absolutely wonderful with a professional staff

Jan 2022

•

Verified SHC Patient

I HAVE THE BEST. HE TALKS TO ME & LISTENS TO ME. HE EXPLAINS THOROUGHLY AND THEN ANSWERS MY QUESTIONS. ANDREA & HIS TEAM HAVE GONE ABOVE EXPECTATIONS TO MAKE SURE THAT I HAVE WHAT I NEED. TEAM IS THE BEST I HAVE EVER HAD I HAVE COMPLETE TRUST KNOW THAT I AM SUPPORTED & SAFE

Jan 2022

•

Verified SHC Patient

Dr Wong and Dr Kebebew were very thorough and answered every question in a forthright manner. I instantly put at ease. Making the decision to have surgery was not difficult, as I knew I had the best possible team with me.

Jan 2022

•

Verified SHC Patient

Thank you Dr. K! I very much enjoyed meeting you and look forward to continuing under your care and that of Dr. Annes. I have a rare condition -- as you know -- and it is reassuring to feel like I am being cared for by world-class experts who have seen other patients with my particular type of tumor and genetic mutation. Wishing you all the best in 2022!

Jan 2022

•

Verified SHC Patient

Superior team of professionals.

Dec 2021

•

Verified SHC Patient

He is wonderful. Thank you so much.

Dec 2021

•

Verified SHC Patient

Thank you for seeing me and making me feel conformable.

Dec 2021

•

Verified SHC Patient

Dr. Kebebew was very reassuring about the results of my recent blood work and biopsy.

Dec 2021

•

Verified SHC Patient

I think he is thorough and clear in his explanations. The entire staff are very good with follow up.

Nov 2021

•

Verified SHC Patient

Knowledgeable, articulate, kind, explained things in detail, did not move on until we understood point.

Nov 2021

•

Verified SHC Patient

He was knowledgable and personable. He asked pointed questions and listened to my responses. He laid out a good first course of action.

Oct 2021

•

Verified SHC Patient

I am pleased with Dr. Electron Kebebew's care & expertise and would not hesitate to recommend him to someone requiring this procedure (parathyroidectomy).

Oct 2021

•

Verified SHC Patient

Nice Doctor..

Oct 2021

•

Verified SHC Patient

Dr Kebebew is an incredible and brilliant doctor! Stanford is extremely lucky to have him.

Sep 2021

•

Verified SHC Patient

Dr. Electron Kebebew is an incredibly kind and knowledgeable physician as well as a gifted surgeon. I appreciate that he always considers the whole patient and not just the disease. I am grateful for his insight in my ongoing care. He provides an opportunity for me to ask questions and voice my concerns. I am so happy that he is at Stanford!

Sep 2021

•

Verified SHC Patient

I appreciate his clarity and detailed explanations about the process.

Sep 2021

•

Verified SHC Patient

I felt very fortunate to have been referred to Dr Kebebew. My care through Stanford and also to his skill was outstanding.

Sep 2021

•

Verified SHC Patient

Excellent doctor.

Sep 2021

•

Verified SHC Patient

Very professional. Made me feel comfortable and seemed genuinely concerned about my health and the procedure I had done.

Sep 2021

•

Verified SHC Patient

I trust what he says and grateful for Dr Kebebew.

Sep 2021

•

Verified SHC Patient

This provider is awesome, he is very detailed in explaining everything, he answers all my questions and the best part I dnt feel rushed in my appointments

Sep 2021

•

Verified SHC Patient

Very thorough on everything. Very efficient doctor

Sep 2021

•

Verified SHC Patient

GAVE EXCELLENT DESCRIPTIONS OF THE PATH FORWARD TO FURTHER DIAGNOSE MY CONDITION. FOUND WAYS TO DO MORE SPECIFIC TESTS LOCALLY WHERE I LIVE SO THAT I WOULD NOT HAVE TO TRAVEL TO CALIFORNIA. SET FOLLOW-UP APPT RIGHT AWAY IN ORDER TO REVIEW UPCOMING TEST RESULTS WHICH HELPS REDUCE TIME WAITING TO DISCUSS WITH DOCTOR.

Aug 2021

•

Verified SHC Patient

Most highly reccomended (by all local physicians)of any other I've encountered

Jul 2021

•

Verified SHC Patient

Very knowledgeable, made me feel comfortable. Very pleased with my care and plan from here.

Jul 2021

•

Verified SHC Patient

Dr K seems to remember me and understand that I like to know the details and not just the conclusion.

Jun 2021

•

Verified SHC Patient

DrK is caring and thorough and skilled and funny and reassuring

Jun 2021

•

Verified SHC Patient

First, I'm honored to have access to such an accomplished doctor. Today the doctor did not mention a newly found mass, which was one of two reasons I was referred to him. When I asked him if it was a reason to worry, he said we'll know after it's imaged. I had hoped for more information.

Jun 2021

•

Verified SHC Patient

Very professional, took time to answer questions, made sure I understood the procedure, and even called the day after I was discharged.

Jun 2021

•

Verified SHC Patient

Compassionate Professional Knowledgeable Friendly Thorough Outstanding patient care Demonstrates patience Great listener Respectful

May 2021

•

Verified SHC Patient

Amazing confidents, great interpreter of medicine.

May 2021

•

Verified SHC Patient

Very much appreciated working with him on this surgery - I liked that prior to the procedure he stopped by to see me, didn't send a resident instead. He came by in the hospital. Answered questions and concerns clearly. Recovery is going very well, and as he had explained it likely would.

May 2021

•

Verified SHC Patient

He was very forthcoming in explaining the pros and cons of the operation without my asking. As well, he did answer the few questions that I had.

Apr 2021

•

Verified SHC Patient

Excellent exchange of medical advice & information.

Feb 2020

•

Verified SHC Patient

All very good!

Feb 2020

•

Verified SHC Patient

Excellent doctor and thank you for calling on Sunday with the results! (The nurse called).

Jan 2020

•

Verified SHC Patient

He took time to explain everything.

Dec 2019

•

Verified SHC Patient

Dr. Kebebew is very friendly and excellent in communications.

Sep 2019

•

Verified SHC Patient

I was totally confident of Dr. Kebebew's diagnosis.

Jun 2019

•

Verified SHC Patient

Dr. Kebebew is an amazing surgeon. He is so competent, kind & caring. He takes time to.

Apr 2019

•

Verified SHC Patient

Dr. Kebebew. Confidence that he passes on to the patient. I trust him with my life and one him my current well being.

Apr 2019

•

Verified SHC Patient

Everything was perfect.

Mar 2019

•

Verified SHC Patient

Dr. Kebebew is amazing! Well spoken easy to talk to, concern for patients A++.

Mar 2019

•

Verified SHC Patient

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday – Friday, 8 a.m. – 5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
View referral status
Access medical records

Learn More About PRISM » LOG INTO PRISM

Adrenal Gland Surgery

Adrenal Nodules

Adrenal Tumors

Complex pancreatic surgery

Endocrine Hypertension

Endocrine Surgery

Enucleation of pancreatic tumors

General Surgery

Goiter

Head and Neck Surgery

Hereditary Endocrine Disorders

Hyperaldosteronism

Hypercalcemia

Hyperparathyroidism

Hyperthyroidism

Hypoglycemia

Insulinoma

Laparoscopic Surgery

Left Upper Pole Partial Adrenalectomy

Minimally Invasive Endoscopy

Minimally invasive pancreatic resections

Minimally invasive parathyroid surgery

Neck Surgery

Neuroendocrine Tumors

Neurofibromatosis

Parathyroid Abnormality

Parathyroid Adenoma

Parathyroid Diseases

Parathyroid Surgery

Parathyroid Tumors and Disorders

Pheochromocytoma

Small Bowel Resection

Small Bowel Tumors

Spleen-preserving pancreatectomy

Surgical Oncology

The "Whipple"

Thyroid Cancer

Thyroid Disease

Thyroid Nodules

Thyroid Surgery

Thyroidectomy

Thyroiditis

Tuberous Sclerosis Complex

Von Hippel-Lindau Syndrome (VHL)

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Electron Kebebew, MD, FACS

Endocrine surgeon

Get In Touch

Biography

Professional Summary

Professional Education

Publications

Clinical Trials

Specializing In

Practice Locations

Cancer Center in Emeryville Emeryville, CA

Cancer Center in Emeryville

Endocrine Tumor Program - 875 Blake Wilbur Drive Palo Alto, CA

Endocrine Tumor Program - 875 Blake Wilbur Drive

Endocrine Tumor Program in Emeryville Emeryville, CA

Endocrine Tumor Program in Emeryville

Neurogenetic Cancer Palo Alto, CA

Neurogenetic Cancer

Patient Ratings

How Our Ratings Work

Patient Reviews

(89 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Electron Kebebew, MD, FACS

Endocrine surgeon

Get In Touch

Biography

Professional Summary

Professional Education

Publications

Clinical Trials

Specializing In

Practice Locations

Cancer Center in Emeryville Emeryville, CA

Cancer Center in Emeryville

Endocrine Tumor Program - 875 Blake Wilbur Drive Palo Alto, CA

Endocrine Tumor Program - 875 Blake Wilbur Drive

Endocrine Tumor Program in Emeryville Emeryville, CA

Endocrine Tumor Program in Emeryville

Neurogenetic Cancer Palo Alto, CA

Neurogenetic Cancer

Patient Ratings

How Our Ratings Work

Patient Reviews

(89 reviews)

Referring Physicians

PHYSICIAN HELPLINE